Tech Company Financing Transactions
Kite Pharma Funding Round
TPG Capital and private investors participated in a $15 million Series A funding round for Kite Pharma. The financing round closed on 3/9/2011.
Transaction Overview
Company Name
Announced On
3/9/2011
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
TPG Capital (David Bonderman)
Proceeds Purpose
The funds will allow us to grow the company, advance our products into clinical development and to expand our pre-clinical pipeline.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2400 Bdwy.
Santa Monica, CA 90404
USA
Santa Monica, CA 90404
USA
Phone
Website
Email Address
Overview
Kite Pharma, Inc. (NASDAQ: KITE) is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arie Belldegrun
Chief Financial Officer
Cynthia Buttita
Chief Scientific Officer
Margo Roberts
VP - Bus. Development
Helen Kim
VP - R & D
David Chang
Browse more venture capital transactions:
Prev: 3/9/2011: Chiasma venture capital transaction
Next: 3/9/2011: Tier 3 venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs